A feline model of spontaneously occurring autoimmune limbic encephalitis
Glantschnigg-Eisl U. et al, (2023), The Veterinary Journal, 296-297, 105974 - 105974
Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis.
Kwon YN. et al, (2022), J Neurol
Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis
Damato V. et al, (2022), Journal of Neurology, Neurosurgery & Psychiatry, 93, 995 - 1000
Utility of Live Cell-Based Assays for Autoimmune Neurology Diagnostics
Woodhall M. et al, (2022), The Journal of Applied Laboratory Medicine, 7, 391 - 393
Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis
Theorell J. et al, (2021), Translational Psychiatry, 11
Progressive encephalomyelitis with rigidity: A Taiwanese case and review of literature
Chang A. et al, (2021), Clinical Neurology and Neurosurgery, 208, 106807 - 106807
Frequency of MOG-IgG in cerebrospinal fluid versus serum
Pace S. et al, (2021), Journal of Neurology, Neurosurgery and Psychiatry
Clinical features which predict neuronal surface autoantibodies in new-onset focal epilepsy: implications for immunotherapies
McGinty RN. et al, (2021), Journal of Neurology, Neurosurgery & Psychiatry, 92, 291 - 294
Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort
Cross H. et al, (2021), Frontiers in Neurology, 11
Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2
Michael S. et al, (2020), Practical Neurology, 20, 377 - 384
Prevalence of NMOSD and MS in the Indigenous Populations of Australia and New Zealand
Broadley SA. et al, (2020), MULTIPLE SCLEROSIS JOURNAL, 26, NP44 - NP44
Serum Cytokine Profiles of Myelin Oligodendrocyte Glycoprotein Encephalomyelitis
Kwon YN. et al, (2020), MULTIPLE SCLEROSIS JOURNAL, 26, NP88 - NP88
Cell-based assays for the detection of MOG antibodies: a comparative study.
Gastaldi M. et al, (2020), J Neurol
Prevalence and incidence of neuromyelitis optica spectrum disorder, aquaporin-4 antibody-positive NMOSD and MOG antibody-positive disease in Oxfordshire, UK.
O'Connell K. et al, (2020), J Neurol Neurosurg Psychiatry
Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms
Ramberger M. et al, (2020), Brain, 143, 1731 - 1745
Cell-based assays for the detection of myelin oligodendrocyte glycoprotein antibodies: a single centre comparative study
Gastaldi M. et al, (2020), EUROPEAN JOURNAL OF NEUROLOGY, 27, 74 - 74
Development Of Silent Brain Lesions In Pediatric Patients With Antibodies To Myelin Oligodendrocyte Glycoprotein
Fadda G. et al, (2020), MULTIPLE SCLEROSIS JOURNAL, 26, 30 - 30
International multicenter examination of MOG antibody assays (vol 7, e674, 2020)
Reindl M. et al, (2020), NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 7